Pneumococcal conjugate second or third-dose vaccines (PCVc) in El Salvador
El Salvador: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 98.0% in 2025. β² Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in El Salvador, 2008β2025
Source: World Health Organization, Global Health Observatory.
Analysis
El Salvador recorded 98.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 2.1% on the previous year and down 1.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in El Salvador peaked at 99.0% in 2015 and was at its lowest, 0.0%, in 2008.
That places El Salvador 10th out of 192 countries with data for 2025, putting it in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 91.0% | 66.0% | 99.0% | 10 |
| 2020s | 94.7% | 90.0% | 99.0% | 6 |
Countries ranked near El Salvador
- 10 Turkmenistan 98.0% compare
- 10 Portugal 98.0% compare
- 10 Costa Rica 98.0% compare
- 10 Saudi Arabia 98.0% compare
- 10 Mauritius 98.0% compare
More health data for El Salvador
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Heat deaths vs projected death rates 1,537 (2090)
- Un projection of annual infant deaths 104 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 64,756 (2025)
- Age population, age 25, female, interpolated 62,076 (2025)
- Age population, age 24, male, interpolated 63,399 (2025)
- Age population, age 24, female, interpolated 60,556 (2025)
- Age population, age 23, male, interpolated 61,274 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in El Salvador?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in El Salvador was 98.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in El Salvador?
- The highest recorded value was 99.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in El Salvador?
- The lowest recorded value was 0.0% in 2008.
- How does El Salvador rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- El Salvador ranks 10th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in El Salvador?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is rising.
- Where does this El Salvador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).